Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Immunotherapy × tremelimumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Liver Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Lung Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Squamous Cell 2 Urothelial Cancer 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Solid Malignancies 1 Seminoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Nonseminomatous germ cell tumor 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma, Malignant 1 Lung Cancer Metastatic 1 Immunotherapy 1 Hypertension, Portal 1 Hydronephrosis 1

Interventions

tremelimumab 1 olaparib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04169841 2024-02-13

GUIDE2REPAIR

Centre Georges Francois Leclerc

Phase 2 Active not recruiting

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡